Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 1531-1540 Newer>

The Motley Fool November 16, 2004 Charly Travers	Finding Biotech's 50-Baggers Finding these superb biotechs isn't a search for a once-in-a-lifetime opportunity. These great investments pop up a lot more frequently than you may think.
BusinessWeek November 22, 2004 Barrett & Carey	Wondering About A Wonder Drug While the benefits of statins, sold under names such as Lipitor and Zocor, are well established, some doctors argue that their side effects have not received adequate scrutiny.
BusinessWeek November 22, 2004 Justin Hibbard	Divvying Up The Stem Cell Bonanza Proposition 71's success will be measured by whether $3 billion in public money has benefited society, or only a handful of private companies.
BusinessWeek November 22, 2004	A Boost For France's Sanofi-Aventis The French government's goal of creating a national pharmaceutical champion got a big boost when Paris-based Sanofi-Aventis released promising data on an experimental drug that helps people lose weight and stop smoking.
HBS Working Knowledge November 15, 2004 Porter & Stewart	Solving the Health Care Conundrum This executive summary of a presentation on reforming health care focuses on how the way in which competition takes place in health care today is at the root of the problems in health care.
The Motley Fool November 15, 2004 Mathew Emmert	Merck's Silver Lining The government joins the plethora of lawsuit filers, but Merck will survive. Still, the stock remains appropriate for only those investors with a high tolerance for risk and a long-term time horizon.
BusinessWeek November 22, 2004 Gene G. Marcial	Diomed Could Get A Boost From Medicare Diomed Holdings, a small medical-device maker, is bound to become a big player in laser removal of varicose veins. So say some investors who bought shares as they fell from 4 in June to 2.59 now
The Motley Fool November 11, 2004 Marko Djuranovic	Take a Shot on CancerVax? The company still isn't profitable, but big gains may be on the horizon for this biotech.
The Motley Fool November 11, 2004 Brian Gorman	Hospira's Possibilities The medical products and services outfit is not flashy, but it may benefit from long-term trends. Their stock may be worth monitoring.
PC World December 2004 Anne Kandra	Trusting Your Health History to the Web Digitized medical records can help save lives. But are they secure enough?
<Older 1531-1540 Newer> Return to current articles.